Breadcrumb
Presentation Materials
The beginning of the end for KRAS cancers
Material Type: Presentation
BI 1823911 as monotherapy and in combination with the pan-KRAS SOS1 inhibitor BI 1701963 in solid tumors expressing KRAS mutation
Material Type: Poster
Pancreatic clonal replica tumors display functional heterogeneity in response to KRAS inhibition
Probing and overcoming KRASG12C inhibitor resistance by combination with a pan-KRAS SOS1 inhibitor
ATP128 vaccine with ezabenlimab promotes antigen-specific immune responses in stage IV colorectal cancer in the KISIMA-01 Phase 1b trial
A first-in-human trial of the heterologous prime-boost vaccine ATP128/ VSV-GP128 with ezabenlimab (BI 754091) in stage IV colorectal cancer
